Trevi Therapeutics, Inc. (TRVI) Analyst/Investor Day - Slideshow
Trevi Therapeutics Inc TRVI
$14.20
▼ -5.84%
($-0.88)
Open
$14.82
Prev Close
$15.08
Day Range
$14.06 – $14.99
52W Range
$5.38 – $16.12
Market Cap
$2.02B
Beta
1.02
EPS (TTM)
$-0.32
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-05-07 |
| Shares Out. | 128,400,000 |
| Website | trevitherapeutics.com/ ↗ |
| Phone | 18004831140 |
Trevi Therapeutics Inc is a publicly traded company under the ticker symbol TRVI on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-05-01)
📰 Latest News for TRVI
Trevi Therapeutics, Inc. (TRVI) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Transcript : Trevi Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 05
Transcript : Trevi Therapeutics, Inc. - Analyst/Investor Day
HC Wainwright & Co. Reiterates Buy on Trevi Therapeutics, Maintains $21 Price Target
Needham Maintains Buy on Trevi Therapeutics, Lowers Price Target to $23
Trevi Therapeutics, Inc. (TRVI) Q1 2026 Earnings Call Transcript
Transcript : Trevi Therapeutics, Inc., Q1 2026 Earnings Call, May 05, 2026